Skip to content
← Back to this collection

PUBLICATIONS · 20192988

Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Haematol
Publication date
2010 Jul
First author
Dimopoulos MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dimopoulos MA
      type
      Author
    2. name
      Christoulas D
      type
      Author
    3. name
      Roussou M
      type
      Author
    4. name
      Kastritis E
      type
      Author
    5. name
      Migkou M
      type
      Author
    6. name
      Gavriatopoulou M
      type
      Author
    7. name
      Matsouka C
      type
      Author
    8. name
      Mparmparoussi D
      type
      Author
    9. name
      Psimenou E
      type
      Author
    10. name
      Grapsa I
      type
      Author
    11. name
      Efstathiou E
      type
      Author
    12. name
      Terpos E
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dimopoulos MA
      type
      Author
    2. name
      Christoulas D
      type
      Author
    3. name
      Roussou M
      type
      Author
    4. name
      Kastritis E
      type
      Author
    5. name
      Migkou M
      type
      Author
    6. name
      Gavriatopoulou M
      type
      Author
    7. name
      Matsouka C
      type
      Author
    8. name
      Mparmparoussi D
      type
      Author
    9. name
      Psimenou E
      type
      Author
    10. name
      Grapsa I
      type
      Author
    11. name
      Efstathiou E
      type
      Author
    12. name
      Terpos E
      type
      Author
    bibliography ids
    1. nci-bib-46433a718359c9dcdfee45b8
    book metadata
    content sha256
    0ec8a1a4dea7c0d45987349f50f2fe03af63ee84231ad8196ae01c8fe1d67144
    document type
    citation
    dois
    1. 10.1111/j.1600-0609.2010.01432.x
    electronic publication date
    display
    2010 Feb 20
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20192988
    immutable id
    pubmed:20192988@0ec8a1a4dea7c0d45987349f50f2fe03af63ee84231ad8196ae01c8fe1d67144
    journal
    abbreviation
    Eur J Haematol
    issn electronic
    1600-0609
    issn print
    0902-4441
    issue
    1
    name
    European journal of haematology
    nlm unique id
    8703985
    pages
    1-5
    volume
    85
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20192988
      provenance
      batch id
      708c7929ee1eff455330
      provider
      NCBI PubMed ESummary
      record sha256
      99c06c264919ac35a9aaa172def1376a4a3443b7b2c68bbfd0f50692fffd5199
      response sha256
      d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
      retrieved at
      2026-09-09T23:46:31.496840+00:00
      publication date
      display
      2010 Jul
      precision
      month
      year
      2010
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20192988/
      title
      Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.

      Preserved source evidence · Not medical advice